Science Explorer Interactive view Map
Company · Lexington · United States

Synta Pharmaceuticals (United States)

ROR OpenAlex
World rank, all time
#23,329
of 42,892
Rank in United States
#5,013
of 8,685
Research works
161
▼ 40% vs 2013–17
Citations
5.5k
34.1 per fractional work
Top-10% rate
23.5%
record average 16.5%
Open access
33%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.94× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 9.32× its world share, 2 worksImmunology and Micro…Chemistry: 0.49× its world share, 0 worksChemistryEngineering: 0.11× its world share, 0 worksEngineeringPhysics and Astronomy: 0.37× its world share, 0 worksPhysics and AstronomyMedicine: 3.66× its world share, 14 worksMedicineNursing: 0.55× its world share, 0 worksNursingEconomics, Econometrics and Finance: 0.23× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.3×. Every wedge is a field page.

Who are the top researchers at Synta Pharmaceuticals (United States)?

Ranked on the composite score, John F. Paolini, David A. Proia and Chaohua Zhang lead among researchers whose main affiliation is Synta Pharmaceuticals (United States).

  1. 1 John F. Paolini United States · #463,795 worldwide 68 citations · 15 works
  2. 2 David A. Proia United States · #1,083,319 worldwide 72 citations · 25 works
  3. 3 Chaohua Zhang United States · #1,563,425 worldwide 14 citations · 23 works
  4. 4 Peter Ordentlich United States · #1,629,020 worldwide 5 citations · 17 works
  5. 5 Jim Sang United States · #1,629,031 worldwide 14 citations · 16 works
All ranked researchers at Synta Pharmaceuticals (United States)

Which keywords describe research at Synta Pharmaceuticals (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Therapy, Echocardiography, Monoclonal Antibodies, Mutation, Constrictive Pericarditis, Pericarditis, Regulation and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Cancer Therapy2▲ 17×4 topics
  2. Echocardiography2▲ 34×2 topics
  3. Epidemiology2▲ 1.98×14 topics
  4. Monoclonal Antibodies2▲ 83×3 topics
  5. Cancer1▲ 5.3×7 topics
  6. Constrictive Pericarditis1▲ 453×1 topic
  7. Mutation1▲ 37×2 topics
  8. Pericarditis1▲ 453×1 topic
  9. Regulation1▲ 13×3 topics
  10. Immunotherapy1▲ 9.2×5 topics
  11. Inflammation1▲ 3.1×10 topics
  12. Therapeutic Antibodies1▲ 88×2 topics
  13. Glycosylation1▲ 48×2 topics
  14. Hematopoietic Stem Cells1▲ 60×3 topics
  15. Prognostic Factors1▲ 12×3 topics
  16. Cell Cycle1▲ 150×1 topic
  17. p531▲ 218×1 topic

Which research topics does Synta Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Pericarditis and Cardiac Tamponade, Cancer-related Molecular Pathways, Monoclonal and Polyclonal Antibodies Research and Myasthenia Gravis and Thymoma.

Pericarditis and Cardiac Tamponade: 1 fractional worksCancer-related Molecular Pathways: 1 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksMyasthenia Gravis and Th…1Myasthenia Gravis and Thymoma: 1 fractional worksAcute Myeloid Leukemia Research: 1 fractional worksProtein Degradation and Inhibitors: 1 fractional worksHemophilia Treatment and…1Hemophilia Treatment and Research: 1 fractional worksMultiple Myeloma Researc…1Multiple Myeloma Research and Treatments: 1 fractional worksPeptidase Inhibition and…0Peptidase Inhibition and Analysis: 0 fractional worksCardiac tumors and thrombi: 0 fractional works
Cardiology and Cardiovascular MedicineOncologyRadiology, Nuclear Medicine and ImagingNeurology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pericarditis and Cardiac Tamponade Cardiology and Cardiovascular Medicine 1 works
  2. 2 Cancer-related Molecular Pathways Oncology 1 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Myasthenia Gravis and Thymoma Neurology 1 works
  5. 5 Acute Myeloid Leukemia Research Hematology 1 works
  6. 6 Protein Degradation and Inhibitors Molecular Biology 1 works
  7. 7 Hemophilia Treatment and Research Hematology 1 works
  8. 8 Multiple Myeloma Research and Treatments Hematology 1 works
  9. 9 Peptidase Inhibition and Analysis Oncology 0 works
  10. 10 Cardiac tumors and thrombi Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.6%not open67.4%

World: 28% of research is openly available.

with international co-authors17.9%domestic only82.1%

World: 19% is written across borders.

How has Synta Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 40% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Lexington

All research institutions in Lexington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.